Amgen was founded in 1980 by a group of scientists and venture capitalists, who officially founded it in 1981. The first product was not launched until 1989, and if this first product had not been launched, or if it had not sold well last time, it is estimated that there would be no future No. 1 biopharmaceutical company.

Gordon S. M. Binder, the president of Amgen, took office the year before last, in 1988, and he served as the company's president until the 21st century.

It can be said that Amgen can become the world's No. 1 biopharmaceutical company in the future. M. Binder definitely deserves a lot of credit for this.

But today.

Gordon S. M. Binder came to Abel's company.

Like everyone who comes to Abel, they appreciate the view of Sunset Boulevard beneath the huge floor-to-ceiling windows on the right-hand side of his office.

Last time Harvey Weinstein was like that, this time this time the Gordon W. The same is true of Mr. M. Binder.

"Truly beautiful view. It's no wonder that many people want to linger in Hollywood, and it's no wonder that Hollywood can become the film capital of the world!" M. Binder admired as he turned around and politely thanked Cameron Diaz, who had brought two cups of coffee, before looking at the young man who was sitting in the chairman's chair and smiling at him.

"Mr. Sephorosa. Your office is perfect! My office is like a calfpen in rural Texas and the best apartment in New York!"

Abel raised an eyebrow.

This legendary manager, and the little William of Pfizer Cstel is one of the future industry leaders in the world pharmaceutical industry.

He smiled and said, "Haha." I'm sure Mr. Binder will be able to enjoy a better office environment if you want. I'm just more of a fan of Hollywood and the sunset over Sunset Boulevard. ”

Gordon S. M. Binder smiled.

"Hmm," he whispered...... then straight to the point, "Mr. Sephorosa." To tell you the truth, I came here to find you this time because I wanted to talk to you about cooperation."

Abel smiled slightly.

"Oh, what are you cooperating? My company's current business doesn't seem to have any business other than participating in the filming of a movie. Is Mr. Binder ready to bring me some other business?"

Gordon S. M. Binder couldn't help but tug at the corners of his mouth......

The fact that Abel Sephorosa, a young genius who invented the promising new drug sildenafil, immediately went to invest in a $30 million medium-sized movie after getting money from Pfizer has become well-known in the American pharmaceutical industry.

The pharmaceutical industry is a competitive market full of life-and-death atmosphere, and in addition to the research and development of new drugs, if you want to survive in the pharmaceutical industry, you must also have 10 points of excellent intelligence ability.

Every pharmaceutical company, the intelligence market for other companies in the industry, has never stopped. After all, a company's R&D route for a new drug, although there will be various patent barriers to be established. However, in addition to patent barriers, if some of this information can be obtained, it is also very effective for the company's own new drug research and development.

Although Amgen Pharma is now only a small point in this industry, and only the R&D and marketing departments are left, it does not dare not invest money in the investment of intelligence in the same industry.

The name Abel Sephorosa is now in the industry because of his previous publications in various academic journals and his dealings with Pfizer.

This time, the young genius released a rumor that he wanted to cooperate with major pharmaceutical companies to conduct research on a new drug.

Most companies are a little moved.

It's just that while they're still thinking about what kind of conditions to use, Gordon M. Binder took the initiative to find the door.

"Investing in movies is also a good business...... Gordon M. M. Binder pondered his words and chuckled softly, "However, Amgen is a pharmaceutical company. What we would like to talk to you, Mr. Sephorosa, is, of course, related to medicine. ”

This Gordon M. M. Binder's personality seems to be very straightforward, and after saying directly that he wanted to cooperate with Abel just now, this time he said directly to the point again:

"Mr. Sephorosa, you have made a noise that you want to cooperate with a pharmaceutical company. Amgen is willing to act as your collaborator, I don't know what kind of cooperation method you want to use, is it a joint venture together, or some other way?"

This time it was Abel's turn to groan.

Amgen wasn't his original purpose, he wanted to work with big companies like Pfizer or Bristol-Myers or Merck. Not to mention Pfizer, the future No. 1 pharmaceutical manufacturer in the universe, is Bristol-Myers and Merck, these two companies can go from now to the next generation, and their scientific research strength and attention to scientific research are very large.

Although Amgen Pharma will be the world's No. 1 biopharmaceutical company in the future, they are now just an unknown small company, and they can only be regarded as start-ups in the pharmaceutical industry.

"What kind of terms can Mr. Binder offer me?" Abel said directly.

Just be willing to bargain.

What businessmen are most afraid of is not bargaining, but what businessmen are most afraid of is that they don't even have the opportunity to bargain. Gordon S. M. Binder was slightly relieved to see Abel's reaction.

Compared with Abel looking for collaborators, Amgen Pharma is now in a predicament with no future.

That's right, next year's Amgen Pharma will launch a blockbuster drug that will be successfully marketed, bringing a lot of revenue and profits to Amgen. It is also this new drug that has allowed this company to officially gain a firm foothold in the pharmaceutical industry.

But now, there is still more than a year before the new drug goes on the market, and Amgen's capital chain is about to break. What's even more troublesome is that the new drug that will be launched next year is now in some trouble during the last review by the FDA.

There are a total of 7 steps in the FDA's review, and the most important step is clinical trials, which must be passed before they can be marketed.

The previous clinical trials were normal, but probably because the samples were too small and the number of people in the trials was insufficient, there were no accidents.

In the last clinical trial, which required at least 3,000 people, there were some problems with the review of new drugs.

In the clinical trial of more than 3,000 people, more than 100 people have different side effects of this new drug.

Although more than 100 people versus more than 3,000 people, there is only about a 3% chance of side effects. But it is a new drug that is about to be marketed, and it actually has a strong side effect rate of about 3%, which is obviously unqualified.

If it weren't for Amgen Pharma begging grandpa to sue grandma to find a relationship everywhere, it might have been directly judged unqualified by the FDA.

Now the situation is stable.

But if the new clinical trial of this new drug is still like this, then no matter what kind of personal relationship there is, the FDA's review will definitely not pass.

And if this new drug is aborted.

Then Amgen Medicine is not far from death.